367 related articles for article (PubMed ID: 33576905)
1. Targeting the purinergic pathway in breast cancer and its therapeutic applications.
de Araújo JB; Kerkhoff VV; de Oliveira Maciel SFV; de Resende E Silva DT
Purinergic Signal; 2021 Jun; 17(2):179-200. PubMed ID: 33576905
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer and Purinergic Signalling: An Overview.
Roliano GG; Azambuja JH; Brunetto VT; Butterfield HE; Kalil AN; Braganhol E
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230810
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
4. Purinergic receptors.
Malec D
Pol J Pharmacol; 1996; 48(5):457-65. PubMed ID: 9112687
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA: Crucial modulator in purinergic signalling involved diseases.
Guo J; Yang P; Li YF; Tang JF; He ZX; Yu SG; Yin HY
Purinergic Signal; 2023 Mar; 19(1):329-341. PubMed ID: 35106737
[TBL] [Abstract][Full Text] [Related]
6. Purinergic receptors in gastrointestinal inflammation.
Kolachala VL; Bajaj R; Chalasani M; Sitaraman SV
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G401-10. PubMed ID: 18063703
[TBL] [Abstract][Full Text] [Related]
7. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
Neary JT; McCarthy M; Kang Y; Zuniga S
Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
[TBL] [Abstract][Full Text] [Related]
8. High CD39 expression is associated with the non-muscle-invasive phenotype of human bladder cancer.
Ferreira JM; Matheus LHG; de Almeida RVS; Melo PAS; Leite KRM; Murta CB; Claro JFA; Camacho CP; Pontes-Júnior J; Dellê H
Oncotarget; 2021 Aug; 12(16):1580-1586. PubMed ID: 34381563
[TBL] [Abstract][Full Text] [Related]
9. Receptors for purines and pyrimidines.
Ralevic V; Burnstock G
Pharmacol Rev; 1998 Sep; 50(3):413-92. PubMed ID: 9755289
[No Abstract] [Full Text] [Related]
10. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
[TBL] [Abstract][Full Text] [Related]
11. Purinergic Receptors in Thrombosis and Inflammation.
Hechler B; Gachet C
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
Chiarella AM; Ryu YK; Manji GA; Rustgi AK
Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
14. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.
Beldi G; Enjyoji K; Wu Y; Miller L; Banz Y; Sun X; Robson SC
Front Biosci; 2008 Jan; 13():2588-603. PubMed ID: 17981736
[TBL] [Abstract][Full Text] [Related]
15. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
[TBL] [Abstract][Full Text] [Related]
16. Ectonucleotidase inhibitors: a patent review (2011-2016).
Al-Rashida M; Qazi SU; Batool N; Hameed A; Iqbal J
Expert Opin Ther Pat; 2017 Dec; 27(12):1291-1304. PubMed ID: 28870136
[TBL] [Abstract][Full Text] [Related]
17. Adenosine inhibits tumor cell invasion via receptor-independent mechanisms.
Virtanen SS; Kukkonen-Macchi A; Vainio M; Elima K; Härkönen PL; Jalkanen S; Yegutkin GG
Mol Cancer Res; 2014 Dec; 12(12):1863-74. PubMed ID: 25080434
[TBL] [Abstract][Full Text] [Related]
18. Purinergic signaling and tumor microenvironment in cervical Cancer.
Pfaffenzeller MS; Franciosi MLM; Cardoso AM
Purinergic Signal; 2020 Mar; 16(1):123-135. PubMed ID: 32170538
[TBL] [Abstract][Full Text] [Related]
19. Agonists and Antagonists for Purinergic Receptors.
Müller CE; Baqi Y; Namasivayam V
Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
[TBL] [Abstract][Full Text] [Related]
20. Signaling by ATP receptors in astrocytes.
Neary JT; Zhu Q
Neuroreport; 1994 Aug; 5(13):1617-20. PubMed ID: 7819532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]